Chinese Therapeutics Startup Harbour BioMed Musters US$102.8M Series C

Harbour BioMed takes its capital pool to well over US$300 million with this round

Shanghai-based biotech startup Harbour BioMed has rounded off its Series C financing with a haul of US$102.8 million, the company announced in a statement today.

Hudson Bay Capital led the round, with participation from OrbiMed, Country Garden VC, GTJA Investment Group, Octagon Capital, and Sage Partners, the statement said. Existing backer Greater Bay Area Homeland Development Fund also joined Harbour BioMed’s league of Series C investors, it added.

With this round of funding, the startup has now raised over $177 million just in the first half of 2020, the statement noted.

The startup had earlier aggregated total funding of $210 million prior to the Series C. With this capital injection, Harbour BioMed’s total funding now stands at $312.8 million, not including its 2018 Series A+ round of an undisclosed amount.

The company had earlier closed its Series B+ financing in March this year, where it raised $75 million from investors including Zhejiang University, Singapore state-owned GIC, and Greater Bay Area Homeland Development Fund.

Harbour BioMed is a clinical stage therapeutics company with operations in Massachusetts, U.S., Rotterdam, the Netherlands, and Suzhou, China, in addition to its headquarters in Shanghai. The company will be focusing its funds toward growing its portfolio of next-gen biologics that target cancer, immunologic diseases, and COVID-19, the statement noted.

Founder, Chairman and CEO of Harbour BioMed, Dr Jingsong Wang said in the statement that the company’s clinical programs were “rapidly moving” to the clinical trials stage.

“The funding will support final development and initial commercialization of our late stage portfolio and advancement of both our earlier stage discovery and preclinical molecules,” he added.

Currently, five of the company’s products are at the clinical development stage, the statement noted. These include monoclonal antibodies (mAb) HBM9161 (Batoclimab), HBM4003, HBM9036 (Tanfanercept).

While Batoclimab is currently in the clinical trial stage in China, with approval from National Medical Products Administration (NMPA) as an investigational new drug (IND), preparations are underway for Phase 3 registration trials for Tanfanercept in China, the statement said.

It added that HBM4003 has received IND approval from the Food and Drug Administration (FDA) for clinical trials in the U.S.

The company has a total of 30 programs targeted toward different types of cancer, all in the preclinical development stage. Additionally, it says it is also developing a “COVID-19 pipeline.”

Harbour BioMed recently announced a research collaboration with American biopharma AbbVie, along with Utrecht University and Erasmus Medical Centre, to study the therapeutic and prophylactic use case of mAb 47D11 targeting the SARS-CoV2 virus, or the novel coronavirus, the statement said.

Further, it added that the company is also working with New York-based Mount Sinai Health System for the discovery of antibodies targeting SARS-CoV2.

Header image by National Cancer Institute on Unsplash

SHARE THIS STORY

Share on facebook
Share on twitter
Share on linkedin
Share on email

RELATED POSTS

Top 5 Clothing Items That Are Contributing to Skims’ Net Worth

Top 5 Clothing Items That Are Contributing to Skims’ Net Worth

In 2022, American media personality Kim Kardashian’s shapewear brand Skims reached a market capitalization of US$3.2 billion. This massive net worth is a byproduct of a lot of factors, such as Kim’s popularity, the brand’s inclusive size range and adaptability (as we saw during the pandemic) to name a few.

5 Companies That Have Already Announced Job Cuts This Year

Layoffs in 2023: 5 Companies That Have Already Announced Job Cuts This Year

The layoff spree at tech giants is bleeding into a new year. It has been just three weeks since we entered 2023, yet the media is buzzing with disturbing numbers about people being laid off by tech companies: At least 104 tech companies let go more than 26,000 employees. This means, more than 1,600 tech employees were dismissed per day in the past couple of weeks. Let’s take a look at the top tech companies that are laying off aggressively.

Goblin Mode

Decoding the World’s Obsession with “Goblin Mode”

Do you find yourself struggling to maintain a positive and productive attitude at work? Are you becoming increasingly irritable or disengaged from constantly feeling overwhelmed and stressed? If so, you’re not alone. Many people experience this state of mind, and some turn on their ‌ “goblin mode” to cope with it. The term “goblin mode” gained popularity in February 2022

Instagram vs YouTube—Which Is Better for Your Business?

Instagram vs YouTubeWhich Is Better for Your Business?

With the rise of social media platforms, like Instagram, TikTok and YouTube, businesses have gained new opportunities to reach their potential customers. It’s important to note that Instagram and YouTube are not just for entertainment; they can be used as powerful tools for marketing and creating brand awareness. Many individuals already use YouTube, TikTok and more to earn money.

What Is Ambient Computing? How Does It Affect Our Lives?

What Is Ambient Computing? How Does It Affect Our Lives?

Picture this: it’s five degrees Celsius outside, and you are freezing, but instead of you adjusting your thermostat, your house automatically realizes that it needs to be warmed up and changes the temperature accordingly. That is what ambient computing is all about. Ambient computing (also called ambient intelligence) refers to technology immersed into your environment. You don’t have to consciously interact with it using screens or keyboards.

How Can AI Be Used in Governance?

How Can AI Be Used in Governance?

One of the many things that artificial intelligence (AI) is capable of doing is helping governments function smoothly. In a previous article, we discussed that, over time, AI would be responsible for more decision-making. As such, it can help governments worldwide make tough decisions by ridding the decision-making process of human biases.